US patent for rapid bacterial vaginosis test:
This article was originally published in Clinica
Executive Summary
Litmus Concepts has received a third US patent covering its rapid test for bacterial vaginosis (BV). The pH and Amines FemExam TestCard, which was approved by the FDA in 1997, produces a qualitative "yes/no" result, providing an objective means of diagnosing the infection. This replaces the subjective "Whiff" test, which requires the healthcare worker to smell for a characteristic amine odour, said the Santa Clara, California-based company. The new patent covers the use of the device to detect BV as a stand-alone product and when used as part of the clinical criteria for diagnosing BV.